American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. (AOB) is an integrated, pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. The Company’s business comprises prescription pharmaceutical products, over-the-counter (OTC) pharmaceutical products and nutraceutical products. Its pharmaceutical products have been approved by the Chinese State Food and Drug Administration (SFDA). The Company sells its products primarily to hospitals, clinics, pharmacies and retail outlets at over 100,000 locations in all provinces, including rural areas and cities in China. During the year ended December 31, 2008, AOB marketed over 60 pharmaceutical products in China. On October 18, 2008, the Company acquired Nuo Hua Investment Company Limited. On October 20, 2008, the Company acquired GuangXi HuiKe Pharmaceutical Research and Development Co., Ltd.
Contact Details
Office Address
American Oriental Bioengineering, Inc.
No.308 Xuefu Road
NanGang District, Harbin, China 150086
Phone: +86-451-8666-6601
Fax: +86-451-8669-0967
Executives
Chairman & Chief Exec. Officer
Mr. Shujun Liu
Co-Founder & Chief Accounting Officer
Mr. Binsheng Li